Basic Information
NeoMedLight Focuses on the Treatment and Prevention of Oral Mucositis and Radiodermatitis, Addressing a Significant Unmet Clinical Need. Mucositis and radiodermatitis are among the most common and debilitating side effects reported by cancer patients undergoing chemotherapy and radiotherapy. NeoMedLight develops innovative medical devices specifically designed for phototherapy.
NeoMedLight
France
less than 15 people
January 01, 2014
contact@neomedlight.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios